ArticleCureus2025
Primary Catastrophic Antiphospholipid Syndrome With Multiple Infarcts in the Kidney, Liver, and Spleen in a Healthy Young Man: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Catastrophic antiphospholipid syndrome (CAPS) is the most aggressive and severe form of antiphospholipid syndrome (APS). Due to its rarity and highly variable clinical presentation, diagnosing CAPS is extremely challenging, often leading to delayed treatment initiation and a high rate of mortality and morbidity. In this paper, we report the case of a 39-year-old male patient with no prior diagnosis of APS who initially presented with deep vein thrombosis in the left leg. The condition rapidly progressed to multiple thromboses in the lungs, liver, spleen, and left kidney. The diagnosis of CAPS was confirmed by the presence of lupus anticoagulant, and treatment was initiated 48 hours after symptom onset with high doses of steroids and anticoagulants. However, the patient developed multiple organ failure and died 72 hours after admission. This paper aims to highlight the rapid progression of CAPS, its fatal complications, and the critical importance of initiating treatment as quickly as possible, even before confirmation through laboratory or histopathological studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.